- Report
- May 2026
- 464 Pages
Global
From €5215EUR$5,850USD£4,510GBP
- Report
- May 2026
- 192 Pages
Global
From €5215EUR$5,850USD£4,510GBP
- Report
- December 2025
- 200 Pages
Global
From €7086EUR$7,950USD£6,128GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2486EUR$2,789USD£2,150GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2486EUR$2,789USD£2,150GBP
- Report
- June 2025
- 150 Pages
Global
From €2406EUR$2,699USD£2,081GBP
- Report
- June 2025
- 400 Pages
Global
From €4411EUR$4,949USD£3,815GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2486EUR$2,789USD£2,150GBP
- Report
- June 2025
- 150 Pages
Global
From €4323EUR$4,850USD£3,739GBP
- Report
- November 2025
- 160 Pages
Global
From €2993EUR$3,358USD£2,588GBP
€3521EUR$3,950USD£3,045GBP
- Report
- May 2026
- 50 Pages
Global
From €2362EUR$2,650USD£2,043GBP
- Report
- May 2026
- 50 Pages
Global
From €2362EUR$2,650USD£2,043GBP
- Report
- June 2025
- 109 Pages
Global
From €3075EUR$3,450USD£2,660GBP
- Report
- June 2025
- 198 Pages
Global
From €4412EUR$4,950USD£3,816GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3521EUR$3,950USD£3,045GBP
- Report
- June 2025
- 100 Pages
Europe
From €3521EUR$3,950USD£3,045GBP
- Report
- June 2025
- 89 Pages
North America
From €3075EUR$3,450USD£2,660GBP
- Report
- June 2025
- 81 Pages
Middle East, Africa
From €3075EUR$3,450USD£2,660GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3209EUR$3,600USD£2,775GBP
- Report
- September 2024
- 110 Pages
Global
From €5304EUR$5,950USD£4,587GBP

Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects.
The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more